ASHLEY BOURGEOIS: Open Payments
NPI 1316403934 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,654 in 79 payments from 23 companies in 2025. Trend: 2023 $1,524 · 2024 $1,520 · 2025 $1,654
Food & beverage: $1,654
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $196 |
| ABBVIE INC. | 13 | $185 |
| Arcutis Biotherapeutics, Inc. | 6 | $169 |
| UCB, Inc. | 7 | $150 |
| Incyte Corporation | 2 | $141 |
| Organogenesis Inc. | 5 | $93 |
| LEO Pharma Inc. | 3 | $82 |
| Organon LLC | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $72 |
Products named: DUPIXENT, Zoryve, Bimzelx, OPZELURA, SKYRIZI, Sotyktu, TREMFYA, NEMLUVIO.
Industry payments across MS — which companies pay providers there.
